Article
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jan 2017
Sarrazin Christoph, Isakov Vasily, Svarovskaia Evguenia S, Hedskog Charlotte, Martin Ross, Chodavarapu Krishna, Brainard Diana M, Miller Michael D, Mo Hongmei, Molina Jean-Michel, Sulkowski Mark S
Abstract excerpt
BACKGROUND: The development of direct-acting antivirals in recent years has dramatically enhanced rates of viral eradication to >90% in patients with chronic hepatitis C virus (HCV) infection. To determine true treatment efficacy and define the most appropriate retreatment, it is important to distinguish virologic relapse from reinfection when patients in whom HCV is eradicated during treatment become infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
